CXNU Conexeu Sciences Inc.: institutional ownership and insider trading
Over the last 12 months insiders bought $1.34M and sold $0 on the open market.
CXNU revenue and earnings
- Quarter ended Jul 31, 2026: revenue n/a, net income −$7.73M, EPS -0.29
- Quarter ended Apr 30, 2026: revenue n/a, net income −$2.30M, EPS -0.11
- Quarter ended Jul 31, 2025: revenue n/a, net income −$1.30M, EPS -0.09
- Quarter ended Apr 30, 2025: revenue n/a, net income −$458K, EPS -0.05
Recent CXNU insider trades
- Oct 15, 2026: Purcell Lynn Sebastian bought 166,666 shares ($500K)
- Jun 18, 2026: Purcell Lynn Sebastian bought 202,500 shares ($162K)
- May 12, 2026: Purcell Lynn Sebastian bought 422,500 shares ($338K)
- May 12, 2026: OnePointTwo Capital Ventures LLC bought 422,500 shares ($338K)
5%+ owners
- Purcell Lynn Sebastian: 12.3% (Schedule 13G, filed Aug 14, 2026)
- Wright Michael G.: 12.1% (Schedule 13G, filed Jul 28, 2026)
- Multi-Valor AIF Umbrella Fund SICAV Quintus Growth Fund: 10.0% (Schedule 13G/A, filed Sep 4, 2026)
- David Bogart: 8.1% (Schedule 13G, filed Aug 18, 2026)
- OnePointTwo Capital Ventures LLC: 6.8% (Schedule 13G, filed Aug 14, 2026)
- Paisley Capital Holdings Corp: 6.7% (Schedule 13G, filed Jul 20, 2026)
Are insiders buying or selling CXNU?
Over the last 12 months insiders bought $1.34M and sold $0 of Conexeu Sciences Inc. stock on the open market (SEC Form 4).